Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ranson

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|April 1, 1994
Acute lymphoblastic leukaemia following Hodgkin's disease is associated with a good prognosisM N Narayanan, G R Morgenstern, J C Chang, et al.
The Journal of Hospital Infection|December 1, 1993
Cutaneous infection with Rhizopus oryzae and Aspergillus niger following bone marrow transplantationA S Johnson, M Ranson, J H Scarffe, et al.
Diseases of the Colon and Rectum|February 11, 2025
Bridging Gaps to Improve Care Models for Patients at Risk for Anal Dysplasia and Cancer: A Call to ActionStacy M Ranson, Linnette M Arroyo-Roldan, Elizabeth C Wick, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
British Journal of Cancer|June 29, 2006
Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAPJ Cummings, M Ranson, E Lacasse, et al.
British Journal of Cancer|May 20, 2004
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancerS Danson, D Ferry, V Alakhov, et al.
British Journal of Cancer|September 22, 2012
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancerA Greystoke, E Dean, M P Saunders, et al.
British Journal of Cancer|February 3, 2005
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAPJ Cummings, T H Ward, E LaCasse, et al.
British Journal of Cancer|February 25, 2009
Biomarkers of apoptosisT H Ward, J Cummings, E Dean, et al.
Biofilm|February 13, 2026
Development of a high-resolution multiplex qPCR method to profile microbial consortia in spaceflight water recovery systemsAmber Dowell Busboom, Jiseon Yang, Taylor M Ranson, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|April 1, 1994
Acute lymphoblastic leukaemia following Hodgkin's disease is associated with a good prognosisM N Narayanan, G R Morgenstern, J C Chang, et al.
The Journal of Hospital Infection|December 1, 1993
Cutaneous infection with Rhizopus oryzae and Aspergillus niger following bone marrow transplantationA S Johnson, M Ranson, J H Scarffe, et al.
Diseases of the Colon and Rectum|February 11, 2025
Bridging Gaps to Improve Care Models for Patients at Risk for Anal Dysplasia and Cancer: A Call to ActionStacy M Ranson, Linnette M Arroyo-Roldan, Elizabeth C Wick, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
British Journal of Cancer|June 29, 2006
Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAPJ Cummings, M Ranson, E Lacasse, et al.
British Journal of Cancer|May 20, 2004
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancerS Danson, D Ferry, V Alakhov, et al.
British Journal of Cancer|September 22, 2012
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancerA Greystoke, E Dean, M P Saunders, et al.
British Journal of Cancer|February 3, 2005
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAPJ Cummings, T H Ward, E LaCasse, et al.
British Journal of Cancer|February 25, 2009
Biomarkers of apoptosisT H Ward, J Cummings, E Dean, et al.
Biofilm|February 13, 2026
Development of a high-resolution multiplex qPCR method to profile microbial consortia in spaceflight water recovery systemsAmber Dowell Busboom, Jiseon Yang, Taylor M Ranson, et al.
Pageof 16